Pathogenic or Not? Classification of genetic variants in haemostasis
In the Wednesday morning lab sciences session on the genetic laboratory for bleeding disorders, Anne Goodeve explains the classification of genetic variants in haemostasis.
State of the Art of the XXXII International Congress of the World Federation of Hemophilia
The freely available special Haemophilia Journal supplement dedicated to the WFH 2016 World Congress Orlando (Vol 22, Issue Supplement S5 Pages 1–95) features reviews of the state of the art of each of the topics of the medical plenaries, medical sessions, and laboratory science sessions at the Congress, written by featured speakers.
Diagnosis of von Willebrand Disease (VWD)
In the Wednesday afternoon session on von Willebrand disease (VWD) Jeroen C.J. Eikenboom explains the diagnosis of von Wilebrand Disease (VWD).
Management of Women with VWD
In the Sunday afternoon joint Laboratory Sciences and VWD Professional Development Workshop, Andra H. James explains the unique issues in the management of women with von Willebrand Disease (VWD). This talk was part of the joint Laboratory Sciences and VWD Professional Development Workshop. See below for the other talks in this workshop:
Stem Cell Gene Therapy of Hemophilia A
In the Tuesday morning session on gene therapy, Christopher B. Doering presents advances in stem cell gene therapy of hemophilia A.
Genomics of Platelet Disorders
In the Wednesday morning medical plenary session, Andrew Mumford presents an overview of the genomics of platelet disorders.
Novel Assays for von Willebrand Factor (VWF) Functional Activity
In the Sunday afternoon joint Laboratory Sciences and VWD Professional Development Workshop, Imre Bodó, explores new von Willebrand factor (VWF) activity assays. This talk was part of the joint Laboratory Sciences and VWD Professional Development Workshop. See below for the other talks in this workshop:
Current Management of Patients with Acquired von Willebrand Syndrome (AVWS): a 2016 update
In the Wednesday afternoon session on von Willebrand disease (VWD), Augusto B. Federici provides a 2016 update on the management of patients with acquired von Willebrand syndrome (AVWS).
Factor VII: From fundamental to bedside
In the Wednesday morning session on rare and ultra-rare bleeding disorders, Jean-François Schved discusses FVII deficiency, one of the more frequent rare bleeding disorders, from the fundamentals to the bedside.
Mechanisms of Tolerance: Immune tolerance induction
In the Monday afternoon session on alternative therapies in the management of inhibitors, David Lillicrap explores the mechanisms of tolerance that are key to immune tolerance induction.
Preventing Bleeds by Treatment: New era for hemophilia
In the Vice President Medical’s plenary of the WFH 2016 World Congress, Marijke van den Berg, discusses how bleeds may be prevented by treatment in a new era for hemophilia which she qualifies as exciting times.
eLearning Modules
Each WFH eLearning Program consists of a series of educational modules designed for individual self-directed or small-group learning. Educational content about hemophilia and other bleeding disorders is brought to life with detailed colour illustrations, interactive features, a glossary of terms, and linked resources for further reading. There are even quizzes, and progress checks so that […]